Charles Ware, MD
Orthopaedic Surgery · Mishawaka, INNPI 1881689834
Payments from drug & device makers
Across 102 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Therapeutics, Inc.$653
- Stryker$346
- Fidia Pharma USA Inc.$211
- Smith+Nephew$205
- Avanos Medical$124
- Ferring Pharmaceuticals Inc.$87
- plus $497 from 16 others
What the payments were for
- Food & beverage$2,124100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Therapeutics, Inc. | 43 | $653 |
| Stryker(2 entities) | 9 | $346 |
| Fidia Pharma USA Inc. | 11 | $211 |
| Smith+Nephew | 8 | $205 |
| Avanos Medical | 1 | $124 |
| Ferring Pharmaceuticals Inc. | 4 | $87 |
| Johnson & Johnson(2 entities) | 5 | $81 |
| Catalyst Orthoscience | 2 | $81 |
| Pfizer | 4 | $61 |
| Orthofix Medical, Inc. | 3 | $41 |
| Dynasplint Systems Inc. | 1 | $40 |
| Medacta USA, Inc. | 1 | $25 |
| Assertio Therapeutics, Inc. | 1 | $23 |
| Nalu Medical, Inc. | 1 | $21 |
| Bioventus LLC | 1 | $20 |
| Linvatec Corporation | 1 | $20 |
| Sanara Medtech Inc. | 1 | $18 |
| Abbott | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Paragon 28, Inc. | 1 | $13 |
| AstraZeneca | 1 | $11 |
| FX Shoulder Solutions, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,124 in reported general payments places this provider in the 35th percentile of 400 orthopaedic surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 128 | $890 |
| Gabapentin | 55 | $439 |
| Cephalexin | 39 | $365 |
| Ketorolac Tromethamine | 22 | $355 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $355 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $187 |
| Methocarbamol | 23 | $163 |
| Diclofenac Sodium | 17 | $161 |
| Cyclobenzaprine Hcl | 31 | $139 |
| Amitriptyline Hcl | 16 | $136 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $90 |
| Amoxicillin | 66 | $75 |
| Diazepam | 26 | $50 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Mishawaka
- Frank KolisekGreenwood$7.6M
- David FisherIndianapolis$5.9M
- Michael BerendIndianapolis$4.1M
- John WilliamsFort Wayne$2.7M
- Alan McGeeFort Wayne$2.3M
- Sanford KunkelIndianapolis$1.9M
- Hill HastingsIndianapolis$1.6M
- Mark KlaassenElkhart$1.4M
- Micah SmithFort Wayne$1.2M
- Lindsey RolstonNew Castle$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.